Key Segmentation:
By Technology
-
Sequencing
-
Polymerase Chain Reaction (PCR)
-
Microarray Technology
-
Nucleic Acid Extraction and Purification
-
Other Techniques
By Products and Service
-
Consumables
-
Systems and Software
-
Services
By Application
-
Diagnostics
-
Drug Discovery
-
Biotechnology
-
Other Applications
By End-User
-
Hospitals and Diagnostic Laboratories
-
Pharmaceutical and Biotechnology Companies
-
Academic and Research Institutes
-
Other End-Users
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key players include Illumina, Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc, Qiagen N.V., bioMérieux S.A., Pacific Biosciences, Agilent Technologies, and Danaher Corporation, among others.
Key opportunities include expanding national antimicrobial resistance surveillance programs, growing microbiome-based drug discovery applications, and continued research and public health market expansion across Asia Pacific and Latin America.
The primary growth factor is the rising global prevalence of infectious diseases, which is driving demand for genomic sequencing of pathogens and antibiotic resistance profiling.
By technology, the Sequencing segment dominates the Microbial Genomics Market with approximately 52.00% share in 2025.
North America dominates the Microbial Genomics Market with approximately 40.00% share in 2025.